Cargando…
CAR T cell-based immunotherapy and radiation therapy: potential, promises and risks
CAR T cell-based therapies have revolutionized the treatment of hematological malignancies such as leukemia and lymphoma within the last years. In contrast to the success in hematological cancers, the treatment of solid tumors with CAR T cells is still a major challenge in the field and attempts to...
Autores principales: | Hovhannisyan, Lusine, Riether, Carsten, Aebersold, Daniel M., Medová, Michaela, Zimmer, Yitzhak |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10176707/ https://www.ncbi.nlm.nih.gov/pubmed/37173782 http://dx.doi.org/10.1186/s12943-023-01775-1 |
Ejemplares similares
-
The Molecular Crosstalk between the MET Receptor Tyrosine Kinase and the DNA Damage Response — Biological and Clinical Aspects
por: Medová, Michaela, et al.
Publicado: (2013) -
An oncogene addiction phosphorylation signature and its derived scores inform tumor responsiveness to targeted therapies
por: Orlando, Eleonora, et al.
Publicado: (2022) -
Correction: An oncogene addiction phosphorylation signature and its derived scores inform tumor responsiveness to targeted therapies
por: Orlando, Eleonora, et al.
Publicado: (2023) -
The relevance of tyrosine kinase inhibitors for global metabolic pathways in cancer
por: Poliaková, Michaela, et al.
Publicado: (2018) -
Prognostic and Predictive Biomarkers in Head and Neck Squamous Cell Carcinoma Treated with Radiotherapy—A Systematic Review
por: Schanne, Daniel H., et al.
Publicado: (2022)